Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Hepatocellular Carcinoma Metastatic”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)UnknownNCT04660929
What this trial is testing

CAR-macrophages for the Treatment of HER2 Overexpressing Solid Tumors

Who this might be right for
HER2-positiveAdenocarcinomaBile Duct Cancer+28 more
Carisma Therapeutics Inc 48
Early research (Phase 1)Study completedNCT01040559
What this trial is testing

Chemoembolisation of Non Resectable, Non Metastatic Hepatocellular Carcinomas

Who this might be right for
Carcinoma, Hepatocellular
Centre Hospitalier Universitaire Dijon 18
Testing effectiveness (Phase 2)Active Not RecruitingNCT06138769
What this trial is testing

Lenvatinib After Progression on Atezolizumab-bevacizumab in Hepatocellular Carcinoma

Who this might be right for
Hepatocellular Carcinoma
Asan Medical Center 50
Early research (Phase 1)Looking for participantsNCT05092373
What this trial is testing

Phase I Study of Tumor Treating Fields (TTF) in Combination With Cabozantinib or With Pembrolizumab and Nab-Paclitaxel in Patients With Advanced Solid Tumors Involving the Abdomen or Thorax

Who this might be right for
Advanced Breast CarcinomaAdvanced Endometrial CarcinomaAdvanced Fallopian Tube Carcinoma+71 more
M.D. Anderson Cancer Center 43
Early research (Phase 1)Study completedNCT00028496
What this trial is testing

Vaccine Therapy With or Without Sargramostim in Treating Patients With Advanced or Metastatic Cancer

Who this might be right for
Adenocarcinoma of the ColonAdenocarcinoma of the GallbladderAdenocarcinoma of the Pancreas+39 more
National Cancer Institute (NCI) 48
Testing effectiveness (Phase 2)Looking for participantsNCT06795022
What this trial is testing

First in Human Study to Evaluate AZD9793 in Participants With Advanced or Metastatic Solid Tumours

Who this might be right for
Hepatocellular Carcinoma
AstraZeneca 304
Early research (Phase 1)Looking for participantsNCT07348211
What this trial is testing

First in Human Study of SIM0610 in Solid Tumors

Who this might be right for
Advanced Solid TumoursNon-Small Cell Lung CancerColorectal Cancer+2 more
Jiangsu Simcere Pharmaceutical Co., Ltd. 260
Early research (Phase 1)Active Not RecruitingNCT03655002
What this trial is testing

IRX-2, Cyclophosphamide, and Nivolumab in Treating Patients With Recurrent or Metastatic and Refractory Liver Cancer

Who this might be right for
Recurrent Hepatocellular CarcinomaRefractory Liver CarcinomaStage IV Hepatocellular Carcinoma AJCC v8+2 more
City of Hope Medical Center 8
Testing effectiveness (Phase 2)Study completedNCT00002655
What this trial is testing

Cryosurgery in Treating Patients With Liver Cancer or Liver Metastases

Who this might be right for
Liver CancerMetastatic Cancer
University of Colorado, Denver
Large-scale testing (Phase 3)UnknownNCT00561522
What this trial is testing

Capecitabine to Prevent Recurrence of Hepatocellular Carcinoma After Curative Resection

Who this might be right for
Hepatocellular CarcinomaNeoplasm Metastasis
Fudan University 290
Very early researchStudy completedNCT03888859
What this trial is testing

ET1402L1-ARTEMIS™2 T Cells in Alpha Fetoprotein (AFP) Expressing Hepatocellular Carcinoma

Who this might be right for
Hepatocellular CarcinomaLiver CancerLiver Neoplasms+1 more
First Affiliated Hospital Xi'an Jiaotong University 12
Not applicableLooking for participantsNCT07650773
What this trial is testing

CHARM Hepatocellular Carcinoma MEA Study

Who this might be right for
HepatoCellular Carcinoma
AstraZeneca 4,000
Testing effectiveness (Phase 2)WithdrawnNCT00493428
What this trial is testing

Treatment of Non-Metastatic Hepatocellular Carcinoma in Humans by Increasing Gabaergic Activity: A Pilot Study

Who this might be right for
Hepatocellular Carcinoma
University of Manitoba
Not applicableLooking for participantsNCT03452774
What this trial is testing

SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry

Who this might be right for
Cancer, MetastaticCancerCancer of Pancreas+40 more
Massive Bio, Inc. 50,000
Not applicableLooking for participantsNCT07636148
What this trial is testing

Registry of Minimally Invasive Cancer Treatment Using Spectral Angio-CT Image Guidance

Who this might be right for
Liver Cancer (Primary and Metastatic)Lung Cancer (Diagnosis)Bone Cancer Metastatic+10 more
Mark C Burgmans, MD PhD 2,000
Testing effectiveness (Phase 2)Ended earlyNCT03480152
What this trial is testing

Messenger RNA (mRNA)-Based, Personalized Cancer Vaccine Against Neoantigens Expressed by the Autologous Cancer

Who this might be right for
MelanomaColon CancerGastrointestinal Cancer+2 more
National Cancer Institute (NCI) 5
Testing effectiveness (Phase 2)Study completedNCT00355238
What this trial is testing

A Phase II Open Label Study of BMS-582664 in Locally Advanced or Metastatic Hepatocellular Cancer

Who this might be right for
Hepatocellular Carcinoma (HCC)
Bristol-Myers Squibb 137
Testing effectiveness (Phase 2)Study completedNCT03211416
What this trial is testing

Sorafenib Tosylate and Pembrolizumab in Treating Patients With Advanced or Metastatic Liver Cancer

Who this might be right for
Advanced Adult Hepatocellular CarcinomaChild-Pugh Class AStage III Hepatocellular Carcinoma+6 more
Roswell Park Cancer Institute 37
Not applicableActive Not RecruitingNCT04572633
What this trial is testing

The HistoSonics System for Treatment of Primary and Metastatic Liver Tumors Using Histotripsy

Who this might be right for
Liver NeoplasmsHepatocellular CarcinomaLiver Metastases
HistoSonics, Inc. 47
Early research (Phase 1)Ended earlyNCT05375604
What this trial is testing

ExoASO-STAT6 (CDK-004) in Patients With Advanced Hepatocellular Carcinoma (HCC) and Patients With Liver Metastases From EIther Primary Gastric Cancer or Colorectal Cancer (CRC)

Who this might be right for
Advanced Hepatocellular Carcinoma (HCC)Gastric Cancer Metastatic to LiverColorectal Cancer Metastatic to Liver
Codiak BioSciences 9
Next Page